Search research articles
Contact Us
Filters
Showing results (31-40 of 391) with videos related to
Page
of 40
Sort By:
Journal of Proteome Research
|
September 9, 2008
Stable isotope labeling tandem mass spectrometry (SILT): integration with peptide identification and extension to data-dependent scans
Donald L Elbert, Kwasi G Mawuenyega, Evan A Scott, et al.
Communications Biology
|
January 28, 2022
Importance of CSF-based Aβ clearance with age in humans increases with declining efficacy of blood-brain barrier/proteolytic pathways
Donald L Elbert, Bruce W Patterson, Brendan P Lucey, et al.
Brain Communications
|
August 21, 2024
Multi-peptide characterization of plasma neurofilament light chain in preclinical and mild Alzheimer's disease
John B Coulton, Yingxin He, Nicolas R Barthélemy, et al.
Annals of Neurology
|
February 15, 2020
Sleep Deprivation Affects Tau Phosphorylation in Human Cerebrospinal Fluid
Nicolas R Barthélemy, Haiyan Liu, William Lu, et al.
Journal of Biomedical Materials Research. Part A
|
January 4, 2012
Exposure of the lysine in the gamma chain dodecapeptide of human fibrinogen is not enhanced by adsorption to poly(ethylene terephthalate) as measured by biotinylation and mass spectrometry
Vitaliy Ovod, Evan A Scott, Megan M Flake, et al.
Nature Medicine
|
June 27, 2006
Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo
Randall J Bateman, Ling Y Munsell, John C Morris, et al.
Brain Communications
|
March 17, 2023
Plasma amyloid-β42/40 and apolipoprotein E for amyloid PET pre-screening in secondary prevention trials of Alzheimer's disease
Nicholas C Cullen, Shorena Janelidze, Erik Stomrud, et al.
Med (New York, N.Y.)
|
September 10, 2024
Fluid biomarkers in the context of amyloid-targeting disease-modifying treatments in Alzheimer's disease
Yan Hu, Min Cho, Pallavi Sachdev, et al.
Alzheimer'S Research & Therapy
|
March 19, 2020
Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer's disease and PET amyloid-positive patient identification
Nicolas R Barthélemy, Randall J Bateman, Christophe Hirtz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Biomarkers
Petrice M Cogswell, Gregory M Preboske, Gregory Klein, et al.
Page
of 40
Search research articles
Search
Showing results (31-40 of 391) with videos related to
Sort By:
Page
of 40
Journal of Proteome Research
|
September 9, 2008
Stable isotope labeling tandem mass spectrometry (SILT): integration with peptide identification and extension to data-dependent scans
Donald L Elbert, Kwasi G Mawuenyega, Evan A Scott, et al.
Communications Biology
|
January 28, 2022
Importance of CSF-based Aβ clearance with age in humans increases with declining efficacy of blood-brain barrier/proteolytic pathways
Donald L Elbert, Bruce W Patterson, Brendan P Lucey, et al.
Brain Communications
|
August 21, 2024
Multi-peptide characterization of plasma neurofilament light chain in preclinical and mild Alzheimer's disease
John B Coulton, Yingxin He, Nicolas R Barthélemy, et al.
Annals of Neurology
|
February 15, 2020
Sleep Deprivation Affects Tau Phosphorylation in Human Cerebrospinal Fluid
Nicolas R Barthélemy, Haiyan Liu, William Lu, et al.
Journal of Biomedical Materials Research. Part A
|
January 4, 2012
Exposure of the lysine in the gamma chain dodecapeptide of human fibrinogen is not enhanced by adsorption to poly(ethylene terephthalate) as measured by biotinylation and mass spectrometry
Vitaliy Ovod, Evan A Scott, Megan M Flake, et al.
Nature Medicine
|
June 27, 2006
Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo
Randall J Bateman, Ling Y Munsell, John C Morris, et al.
Brain Communications
|
March 17, 2023
Plasma amyloid-β42/40 and apolipoprotein E for amyloid PET pre-screening in secondary prevention trials of Alzheimer's disease
Nicholas C Cullen, Shorena Janelidze, Erik Stomrud, et al.
Med (New York, N.Y.)
|
September 10, 2024
Fluid biomarkers in the context of amyloid-targeting disease-modifying treatments in Alzheimer's disease
Yan Hu, Min Cho, Pallavi Sachdev, et al.
Alzheimer'S Research & Therapy
|
March 19, 2020
Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer's disease and PET amyloid-positive patient identification
Nicolas R Barthélemy, Randall J Bateman, Christophe Hirtz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Biomarkers
Petrice M Cogswell, Gregory M Preboske, Gregory Klein, et al.
Page
of 40